Ad Hoc Percutaneous Coronary Intervention study in Acute Coronary Syndrome patients

Study identifier:D5130L00014

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomized, open-label study to compare the platelet inhibition with VerifyNow assay of ticagrelor versus clopidogrel in troponin negative Acute Coronary Syndrome subjects undergoing Ad Hoc percutaneous coronary intervention

Medical condition

Acute Coronary Syndrome

Phase

Phase 4

Healthy volunteers

No

Study drug

Ticagrelor, Clopidogrel

Sex

All

Actual Enrollment

343

Study type

Interventional

Age

18 Years - 130 Years

Date

Study Start Date: 01 Jul 2012
Primary Completion Date: 01 Jun 2014
Study Completion Date: 01 Jun 2014

Study design

Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria